As these neurons degenerate, amyloid plaques may form and incorporate portions of the degenerating neurons and other neural and glial processes in the immediate environment. The pattern of these early neurodegenerative and reactive events will follow the pattern of distribution of the specific neurons vulnerable to this amyloid/NMDA receptor-mediated neuropathological process. We postulate that it may not be a very conspicuous

pattern of neuronal loss because it may be restricted to Inhibitors,research,lifescience,medical just the NMDA receptor-bearing neurons in our schematic circuit, that, control the release of transmitters onto the vulnerable pyramidal neuron (Figure 1). In stage I, the neurodegenerative Inhibitors,research,lifescience,medical process may produce few if any symptoms, because it. is limited to a. small population of neurons. In addition, we postulate that, the recurrent collateral feedback loop (Figure 1) remains relatively intact, so that, pyramidal neurons, as they begin to receive excessive stimulation, will be prevented from firing

erratically onto other neurons and thereby prevented from generating florid symptoms. The second Inhibitors,research,lifescience,medical stage commences when the loss of NMDA receptor-bearing neurons is sufficient, to substantially unleash the disinhibition syndrome in which many primary cerebrocortical and corticolimbic neurons are pathologically hyperstimulated selleck screening library through several signal transduction pathways at the same time. At this point, psychosis and NRHypo-related cognitive disturbances could become evident. We propose that pyramidal

neurons in many cortical Inhibitors,research,lifescience,medical and limbic brain regions will be affected, and will slowly degenerate and die as the stage II process progresses. Death and deletion of these neurons will disrupt mental functions just as excessive hyperactivation of these neurons will disrupt these functions. While these neurons are degenerating, Inhibitors,research,lifescience,medical we propose that at least some of them develop NFTs on the basis of excessive activation of second messenger pathways associated with muscarinic and/or non-NMDA glutamate receptors. These second messenger systems are coupled to kinases or other possible factors Carfilzomib relevant to protein phosphorylation; therefore, hyperactivation of these systems provides a rational explanation for NFT formation, which is believed to result from hyperphosphorylation of microtubule-associated proteins. In stage II, neurodegeneration occurs as a network disturbance. The pattern of degeneration is determined by the pattern of connections within the network, and by the failure of inhibition over license with Pfizer certain excitatory pathways within the network, causing specific cortical and limbic neurons innervated by these excitatory pathways to degenerate. This provides a rational explanation for the pattern of degeneration seen in AD.